Clinical Trial Update: An Interaction Study With Digoxin and AZD1305 [Phase 1]

View source ↗

Summary

A Phase 1 interaction study evaluating digoxin with AZD1305 in atrial fibrillation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AZD1305
• DIGOXIN (Digoxin)

Snippet

Sponsor: AstraZeneca | Conditions: Atrial Fibrillation | Phase 1 | Status: COMPLETED